We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$82.6M
Cap. Flow
+$147M
Cap. Flow %
6.86%
Top 10 Hldgs %
24.87%
Holding
174
New
31
Increased
73
Reduced
40
Closed
27

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$26M
2
FISV
Fiserv Inc
FISV
+$24M
3
OMC icon
Omnicom Group
OMC
+$19.5M
4
OC icon
Owens Corning
OC
+$19.2M
5
MOS icon
The Mosaic Company
MOS
+$18.3M

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$24.3M
2
BKH icon
Black Hills Corp
BKH
+$19.6M
3
SEE
Sealed Air
SEE
+$15.5M
4
UHS icon
Universal Health Services
UHS
+$15M
5
GOLD
Gold.com Inc
GOLD
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 20.83%
2 Healthcare 17.07%
3 Consumer Discretionary 14.96%
4 Materials 11.78%
5 Industrials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATNI icon
151
ATN International
ATNI
$490M
– –
-183,505
Closed -$2.75M
BKH icon
152
Black Hills Corp
BKH
$5.62B
– –
-318,356
Closed -$19.6M
BTG icon
153
B2Gold
BTG
$6.67B
– –
-990,484
Closed -$4.9M
BXC icon
154
BlueLinx
BXC
$713M
– –
-27,000
Closed -$1.97M
CENX icon
155
Century Aluminum
CENX
$5.14B
– –
-155,269
Closed -$4.56M
EVTC icon
156
Evertec
EVTC
$1.78B
– –
-247,541
Closed -$8.36M
B
157
Barrick Mining
B
$68.3B
– –
-194,931
Closed -$6.39M
HAE icon
158
Haemonetics
HAE
$3.93B
– –
-498,317
Closed -$24.3M
HSII
159
DELISTED
Heidrick & Struggles
HSII
– –
-88,176
Closed -$4.39M
IQV icon
160
IQVIA
IQV
$40B
– –
-57,248
Closed -$10.9M
JAMF
161
DELISTED
Jamf
JAMF
– –
-1,204,461
Closed -$12.9M
KHC icon
162
Kraft Heinz
KHC
$29.3B
– –
-498,384
Closed -$13M
KMX icon
163
CarMax
KMX
$8.43B
– –
-78,349
Closed -$3.52M
PRTH icon
164
Priority Technology Holdings
PRTH
$432M
– –
-335,881
Closed -$2.31M
RGNX icon
165
Regenxbio
RGNX
$688M
– –
-426,904
Closed -$4.12M
RSKD icon
166
Riskified
RSKD
$715M
– –
-552,416
Closed -$2.59M
SEE
167
DELISTED
Sealed Air
SEE
– –
-438,282
Closed -$15.5M
SPY icon
168
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-75,400
Closed -$50.2M
TCMD icon
169
Tactile Systems Technology
TCMD
$669M
– –
-353,657
Closed -$4.89M
TDOC icon
170
Teladoc Health
TDOC
$1.28B
– –
-1,372,977
Closed -$10.6M
UHS icon
171
Universal Health Services
UHS
$10.5B
– –
-73,266
Closed -$15M
VRNT
172
DELISTED
Verint Systems
VRNT
– –
-100,000
Closed -$2.02M
VTOL icon
173
Bristow Group
VTOL
$1.37B
– –
-132,596
Closed -$4.78M
WBD icon
174
Warner Bros
WBD
$67.4B
– –
-409,365
Closed -$7.99M
3 4 5 6
7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Invenomic Capital Management held 174 positions worth $2.15B, up 4% from $2.07B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $147M of net new capital in Q4 2025, opening 31 new positions and adding to 73 existing holdings. Its largest new stake was Fiserv Inc: 287,266 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $13.2M trimmed.

  • Invenomic Capital Management's largest Q4 2025 buy was Fiserv Inc: 287,266 shares worth $19.3M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q4 2025, an estimated $26M increase.
  • Invenomic Capital Management's biggest Q4 2025 reduction was Verizon, cutting an estimated $13.2M.
  • Invenomic Capital Management fully exited Haemonetics in Q4 2025, selling an estimated $24.3M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.15B portfolio in Q4 2025.
  • Invenomic Capital Management opened 31 new positions and closed 27 in Q4 2025.
  • Invenomic Capital Management's portfolio value rose 4% quarter-over-quarter to $2.15B.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.